### **Overview** Orient Paper & Industries Ltd (OPIL), a part of the respected CK Birla Group, is transforming from a traditional paper manufacturer into a **sustainable, customer-centric, value-added products company**. With a legacy dating back to 1936, OPIL has evolved strategically to navigate industry headwinds and capitalize on high-growth, eco-conscious markets—particularly in **tissue, specialty paper, and sustainable alternatives to plastic**. The company is shifting focus from low-margin **Writing & Printing Paper (WPP)** to high-margin, environmentally responsible offerings such as **bamboo-based tissue, copier paper, and plastic substitutes**, reinforcing its position as India’s largest tissue paper producer and a pioneer in virgin bamboo tissue. --- ### **Strategic Transformation & Business Focus (2022–2025)** #### **1. Shift from WPP to Higher-Margin, Sustainable Products** - **Strategic Realignment**: OPIL is deprioritizing commoditized WPP, where demand is declining due to reduced printing and publishing activity. - **Growth Pillars**: - **Bamboo-Based Tissue**: High-growth, eco-friendly products such as *Orient Bamboo Natura*. - **Copier Paper**: Steady demand from offices, education, and retail sectors. - **Plastic Substitutes**: Eco-friendly cup stocks, carry bags, food wraps, and packaging papers. > **Key Insight**: Tissue became the **primary value driver in FY 2024–25**, with 275% sales growth, driven by institutional adoption and premium positioning. #### **2. Sustainability & Raw Material Security** - **Plantation Expansion**: - Expanded pulpwood plantations from 36,000 acres (2023) to **~58,000 acres by FY 2025–26**. - Aims to increase **in-house raw material sourcing from 40–45% to 80%**, reducing dependency on imports. - **Agroforestry & Farmer Partnerships**: - Collaborations with **FPOs, NGOs, and Chhattisgarh government** to support 90,000+ farmers across 1,089 villages. - Clonal sapling production increased **49% YoY (FY 2022–23)** with a target for **70% growth by FY 2024–25**. > **Sustainability Goal**: Drive circular, inclusive value chains and achieve **first-mover leadership** in green procurement markets. #### **3. Product Innovation & Value-Addition** OPIL has launched **over 30 new products since FY 2022–23**, emphasizing: - **Bamboo Natura** (India’s first virgin bamboo tissue). - **OBA-Free (Optical Brightener-Free) Tissue** – eco-safe, cost-efficient. - **Specialty Papers**: High-GSM cup stock (110–140 GSM), thermal coating base, absorbent kraft (LamiKraft), and pigment-dyed WPP. - **Plastic Alternatives**: Paper-based carry bags, Ice Cone wrap, and sanitary napkin carrier tissue. > **Innovation Engine**: Fueled by customer insights from **Mission Khushi**, Hub Meets, and co-creation with converters. #### **4. Technological & Digital Transformation (Industry 4.0)** - **Process Upgrades**: - Implementation of **APC (Advanced Process Control)**, **QCS**, and **DCS systems** to improve brightness consistency, reduce costs, and boost machine uptime. - Retrofitted tissue and WPP machines with support from **Valmet, Andritz, Siemens, and Reotech**. - **Digital Integration**: - **SAP HANA** for real-time data and analytics. - **AI-ML based closed-loop manufacturing** roadmap for enhanced agility and predictive maintenance. - **Modernization CapEx**: Total spending of **₹5,577.62 crore**, with ₹3,268.55 crore incurred and ₹2,309.07 crore ongoing. > **Energy Transition**: Targeting **43% renewable energy sourcing by Q2 FY 2025**, reducing coal dependency and emissions. --- ### **Market & Customer Strategy** - **Customer-Centric Ecosystem**: - Launched **digital engagement platforms** (Orient Stars, Hub Meets) for converters. - Developed **Orient Ingredient brand** based on customer-valued features. - Deep mapping of tissue value chain (dealers, HoReCa, institutions). - **Export Strategy**: - Focused on **high-margin global markets**, with tissue exports now including the USA. - Weak rupee supports export competitiveness and reduces import pressure. - **Institutional Wins**: - **Sole supplier of bamboo tissue at Mumbai International Airport** – a key credibility milestone. --- ### **Operational & Financial Highlights (FY 2023–2025)** | Metric | Performance | |-------|-------------| | **WPP Output Growth** | 13% YoY (FY 2024–25) | | **Tissue Sales Growth** | 275% YoY (FY 2024–25) | | **Record Paper Production** | 8,652 tonnes in March 2024 (all-time high) | | **Value-Added Products (VAP) Share** | >60% of portfolio | | **Capex (FY 2024–25)** | ₹5,577.62 crore (includes ₹501 crore pulp mill upgrade to 400 TPD) | --- ### **Segment-Wise Business Portfolio** | Segment | Key Products | Strategy | |--------|--------------|--------| | **Wellness & Hygiene** | Orient Tissue, Bamboo Natura, OBA-Free, Ultra-Soft Tissue | Lead eco-conscious and virgin tissue space; premium hygiene positioning | | **Writing & Printing (WPP)** | Orient Platinum, Peacock, Cartridge, Maplitho | Premium, sustainable papers aligned with education policy; shift to higher GSM | | **Chemical Solutions** | Caustic Soda, Chlorine, Bleaching Powder, HCl, Sodium Hypochlorite | Support industrial clients in water treatment, sanitation, and manufacturing |